Dare Bioscience Inc (DARE)
0.3112
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3112
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Shareholders Equity (Quarterly): -5.048M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.048M |
| September 30, 2023 | -2.289M |
| June 30, 2023 | -2.719M |
| March 31, 2023 | 4.972M |
| December 31, 2022 | 11.11M |
| September 30, 2022 | 26.34M |
| June 30, 2022 | 33.03M |
| March 31, 2022 | 30.88M |
| December 31, 2021 | 38.75M |
| September 30, 2021 | 31.89M |
| June 30, 2021 | 7.744M |
| March 31, 2021 | 3.258M |
| December 31, 2020 | -1.152M |
| September 30, 2020 | -1.386M |
| June 30, 2020 | 0.3113M |
| March 31, 2020 | 3.214M |
| December 31, 2019 | 0.4408M |
| September 30, 2019 | 1.81M |
| June 30, 2019 | 5.083M |
| March 31, 2019 | 3.780M |
| December 31, 2018 | 6.727M |
| Date | Value |
|---|---|
| September 30, 2018 | 9.584M |
| June 30, 2018 | 12.22M |
| March 31, 2018 | 15.82M |
| December 31, 2017 | 13.29M |
| September 30, 2017 | 22.43M |
| June 30, 2017 | 4.059M |
| March 31, 2017 | 7.741M |
| December 31, 2016 | -0.7106M |
| September 30, 2016 | 16.62M |
| June 30, 2016 | 25.84M |
| March 31, 2016 | 35.98M |
| December 31, 2015 | 48.74M |
| September 30, 2015 | 58.64M |
| June 30, 2015 | 68.20M |
| March 31, 2015 | 40.41M |
| December 31, 2014 | 45.32M |
| September 30, 2014 | 52.53M |
| June 30, 2014 | 57.81M |
| March 31, 2014 | -97.04M |
| December 31, 2013 | -94.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.048M
Minimum
Dec 2023
38.75M
Maximum
Dec 2021
9.803M
Average
3.258M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Altimmune Inc | 194.10M |
| Verastem Inc | 57.37M |
| Oragenics Inc | 3.168M |
| Actinium Pharmaceuticals Inc | 43.86M |
| Orgenesis Inc | -20.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.28M |
| Total Liabilities (Quarterly) | 26.33M |
| Current Ratio | 0.8566 |